Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Ninan

Showing results (91-100 of 117) with videos related to

Pageof 12
Sort By:
Archives of Disease in Childhood|May 13, 2022
Do you know when the inhaler is empty?I Fullwood, T Evans, Benjamin Davies, et al.
Journal of Clinical Psychopharmacology|November 16, 2007
Coadministration of modafinil and a selective serotonin reuptake inhibitor from the initiation of treatment of major depressive disorder with fatigue and sleepiness: a double-blind, placebo-controlled studyBoadie W Dunlop, Paul Crits-Christoph, Dwight L Evans, et al.
The Journal of Clinical Psychiatry|July 13, 1999
Lithium augmentation fails to reduce symptoms in poorly responsive schizophrenic outpatientsS C Schulz, P A Thompson, M Jacobs, et al.
CNS Drugs|February 18, 2011
Open-label treatment with desvenlafaxine in postmenopausal women with major depressive disorder not responding to acute treatment with desvenlafaxine or escitalopramClaudio N Soares, Michael E Thase, Anita Clayton, et al.
Transplantation Proceedings|September 8, 2004
Baseline cardiac troponin I in patients on maintenance dialysisV T Ninan, N Hilali, J H Ali, et al.
Brain Stimulation|July 17, 2010
A pilot study of vagus nerve stimulation (VNS) for treatment-resistant anxiety disordersMark S George, Herbert E Ward, Philip T Ninan, et al.
Transplantation Proceedings|January 3, 2006
Vascular calcification in dialysis patientsH Al Humoud, N Al-Hilali, A A M H Ahmad, et al.
The Journal of Clinical Psychiatry|December 19, 2013
Influence of sex and menopausal status on response, remission, and recurrence in patients with recurrent major depressive disorder treated with venlafaxine extended release or fluoxetine: analysis of data from the PREVENT studySusan G Kornstein, Ronald D Pedersen, Peter J Holland, et al.
Science (New York, N.Y.)|May 27, 1983
Dopamine-beta-hydroxylase activity and homovanillic acid in spinal fluid of schizophrenics with brain atrophyD P van Kammen, L S Mann, D E Sternberg, et al.
International Clinical Psychopharmacology|October 16, 2008
Assessing the efficacy of 2 years of maintenance treatment with venlafaxine extended release 75-225 mg/day in patients with recurrent major depression: a secondary analysis of data from the PREVENT studySusan G Kornstein, James H Kocsis, Saeeduddin Ahmed, et al.
Pageof 12

Showing results (91-100 of 117) with videos related to

Sort By:
Pageof 12
Archives of Disease in Childhood|May 13, 2022
Do you know when the inhaler is empty?I Fullwood, T Evans, Benjamin Davies, et al.
Journal of Clinical Psychopharmacology|November 16, 2007
Coadministration of modafinil and a selective serotonin reuptake inhibitor from the initiation of treatment of major depressive disorder with fatigue and sleepiness: a double-blind, placebo-controlled studyBoadie W Dunlop, Paul Crits-Christoph, Dwight L Evans, et al.
The Journal of Clinical Psychiatry|July 13, 1999
Lithium augmentation fails to reduce symptoms in poorly responsive schizophrenic outpatientsS C Schulz, P A Thompson, M Jacobs, et al.
CNS Drugs|February 18, 2011
Open-label treatment with desvenlafaxine in postmenopausal women with major depressive disorder not responding to acute treatment with desvenlafaxine or escitalopramClaudio N Soares, Michael E Thase, Anita Clayton, et al.
Transplantation Proceedings|September 8, 2004
Baseline cardiac troponin I in patients on maintenance dialysisV T Ninan, N Hilali, J H Ali, et al.
Brain Stimulation|July 17, 2010
A pilot study of vagus nerve stimulation (VNS) for treatment-resistant anxiety disordersMark S George, Herbert E Ward, Philip T Ninan, et al.
Transplantation Proceedings|January 3, 2006
Vascular calcification in dialysis patientsH Al Humoud, N Al-Hilali, A A M H Ahmad, et al.
The Journal of Clinical Psychiatry|December 19, 2013
Influence of sex and menopausal status on response, remission, and recurrence in patients with recurrent major depressive disorder treated with venlafaxine extended release or fluoxetine: analysis of data from the PREVENT studySusan G Kornstein, Ronald D Pedersen, Peter J Holland, et al.
Science (New York, N.Y.)|May 27, 1983
Dopamine-beta-hydroxylase activity and homovanillic acid in spinal fluid of schizophrenics with brain atrophyD P van Kammen, L S Mann, D E Sternberg, et al.
International Clinical Psychopharmacology|October 16, 2008
Assessing the efficacy of 2 years of maintenance treatment with venlafaxine extended release 75-225 mg/day in patients with recurrent major depression: a secondary analysis of data from the PREVENT studySusan G Kornstein, James H Kocsis, Saeeduddin Ahmed, et al.
Pageof 12